GTI-4711-201 GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711

Administered By

Radiation Oncology

Awarded By

Galera Therapeutics, Inc.

Contributors

Palta, Manisha Principal Investigator

Start/End

June 23, 2021 - February 29, 2024